Immunomodulatory nanogels overcome restricted immunity in a murine model of gut microbiome-mediated metabolic syndrome

Visibility: Public
Publication: Immunomodulatory nanogels overcome restricted immunity in a murine model of gut microbiome-mediated metabolic syndrome Link
Journal: Science Advances
Source: Link to the source page
Sample Number: 48

Samples in this project
  

SampleID Type Habitat Year Sequence type MNS1 MAS2
S_SRP181160.SRR8496312 Mammal_animal UBERON:feces 2018 16S NA - -
S_SRP181160.SRR8496313 Mammal_animal UBERON:feces 2018 16S NA - -
S_SRP181160.SRR8496314 Mammal_animal UBERON:feces 2018 16S NA - -
S_SRP181160.SRR8496315 Mammal_animal UBERON:feces 2018 16S NA - -
S_SRP181160.SRR8496316 Mammal_animal UBERON:feces 2018 16S NA - -
S_SRP181160.SRR8496317 Mammal_animal UBERON:feces 2018 16S NA - -
S_SRP181160.SRR8496318 Mammal_animal UBERON:feces 2018 16S NA - -
S_SRP181160.SRR8496319 Mammal_animal UBERON:feces 2018 16S NA - -

1MNS (Microbiome Novelty Score): < 0.12: Non-novel; 0.12-0.2: Novel; > 0.2: Very novel; -: NA for samples before 2010

2MAS (Microbiome Attention Score): < 10: Low-attention; ≥ 10: High-attention; -: NA for samples before 2010